Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Drug Development

      OncoImmune, Inc. Raises $56 Million Series B Financing for Novel Cancer and COVID-19 Therapeutics

      Drug Development
      OncoImmune, Inc. announced the completion of a $56 million financing in Series B equity co-led by HM Capital and a blue-chip investor. Existing investors,...

      Sharp launches Clinventory Inventory Management System (IMS) for clinical trials

      Clinical Trials
      Sharp – part of UDG Healthcare plc, a global leader in contract packaging clinical supply services, has launched a new Inventory Management System (IMS)...

      Blueprint and Roche Take on Lilly As FDA Approves RET-Targeting Lung Cancer Drug

      FDA Approvals
      Cancer drugs firm Blueprint Medicines has gained a second US approval, with its Gavreto (pralsetinib) daily pill that targets non-small cell lung cancer with...

      RECOVERY COVID-19 Phase 3 Trial to Evaluate Regeneron’s REGN-COV2 Investigational Antibody Cocktail in the UK

      Clinical Trials
      Regeneron Pharmaceuticals, Inc. and the University of Oxford announced that RECOVERY (Randomised Evaluation of COVid-19 thERapY), one of the world’s largest randomized clinical trials...

      Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer

      FDA Approvals
      Roche announced U.S. FDA approval for the expanded use of CINtec® PLUS Cytology, the first triage test based on biomarker technology for women whose...

      Moderna and Chiesi Group Establish Collaboration to Discover and Develop mRNA Therapeutics for PAH

      Drug Development
      Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients and Chiesi...

      Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trial of STI-1499 Neutralizing Antibody in COVID-19 Positive Patients

      FDA Approvals
      Sorrento Therapeutics, Inc. announced that it received a study may proceed letter from the FDA for its phase 1 clinical trial for COVI-GUARD (STI-1499)...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.